Get started
Author

Attila Imre

Observed name: Imre, Attila
ORCID: 0009-0004-0110-8395
Observed ORCID: 0009-0004-0110-8395
OpenAlex ID: A5114745015
GraphCPP: The new state‐of‐the‐art method for cell‐penetrating peptide prediction via graph neural networks
2024 · Attila Imre, Balázs Balogh, et al. · British Journal of Pharmacology · 28
PDF
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
2025 · Attila Imre, Balázs Nagy, et al. · British Journal of Clinical Pharmacology · 4
PDF
Early-stage assessment of investigational digital technologies in mental health: a guide for innovators
2025 · Zoltán Kaló, Attila Imre, et al. · Psychiatry Research · 4
The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data
2026 · Attila Imre, Ágota Mészáros, et al. · Health Economics Review · 2
Machine learning-assisted retention time predictions on a cellulose Tris(3,5)-dimethylphenylcarbamate column in polar organic mode
2025 · Attila Imre, Gergely Dombi, et al. · Analytica Chimica Acta · 2
Generating Realistic Synthetic Patient Cohorts: Enforcing Statistical Distributions, Correlations, and Logical Constraints
2025 · Ahmad Nader Fasseeh, Rasha Ashmawy, et al. · Algorithms · 2
PDF
Assessing the Early Economic Feasibility of a Curative Gene Therapy for Multiple Sclerosis Using a Risk-Adjusted Valuation Framework
2026 · Attila Imre, Balázs Nagy, et al. · Healthcare · 1
PDF
Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products
2025 · Zoltán Kaló, Attila Imre, et al. · British Journal of Clinical Pharmacology · 1
PDF
From general-purpose models to purpose-built artificial intelligence systems for health economic modeling
2026 · Attila Imre, Bertalan Nemeth, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
Early cost-effectiveness analysis of the U-Care Renal Platform
2026 · Attila Imre, György Tímár, et al. · BMC Nephrology
REFLECTIVE-TIAB: cost-effective prompt optimization for large language model-based title and abstract screening in literature reviews
2026 · Ákos Józwiak, Attila Imre, et al. · Figshare
REFLECTIVE-TIAB: cost-effective prompt optimization for large language model-based title and abstract screening in literature reviews
2026 · Ákos Józwiak, Attila Imre, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
Msr71 Can Artificial Intelligence Assisted Systematic Literature Review Support Rigorous Evidence Generation? a Case Study on Predictors of Copd Exacerbations
2026 · Ákos Bernard Józwiak, Judit Józwiak-Hagymásy, et al. · Value in Health
Msr231 Evaluation of Off-the-shelf Agent-based Ai Tool Claude Code for Rapid Replication of a Published Cost-effectiveness Model
2026 · Attila Imre, Bertalan Németh, et al. · Value in Health
Ee305 Generative Ai in Health Economic Modelling: a Targeted Review of Emerging Applications and Methodological Gaps
2026 · Attila Imre, Bertalan Németh, et al. · Value in Health
Variation in use of PROMs and geographical distribution in clinical trials of selected hematological diseases in Europe
2026 · Mercè Cases, Attila Imre, et al. · Blood Global Hematology
The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data
2026 · Imre, Attila, Mészáros, Ágota, et al. · Figshare
Additional file 1 of The global economic burden of schizophrenia: an umbrella review of systematic reviews and meta-analyses with reconstructed primary-study cost data
2026 · Imre, Attila, Mészáros, Ágota, et al. · Figshare
Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025
2026 · Mimi Choon‐Quinones, George Dennis Obeng, et al. · European Journal Of Haematology
EE348 Early Stage Health Economic Evaluation of IMMUTOL Gene Therapy for Relapsing/Remitting Multiple Sclerosis in the Netherlands
2025 · Attila Imre, Rok Hren, et al. · Value in Health
The Global Economic Burden of Schizophrenia: An Umbrella Review of Systematic Reviews and Meta-Analyses
2025 · Attila Imre, Ágota Mészáros, et al. · medRxiv
PDF
Geographic Inequities in Patient-Reported Outcome Measures in Clinical Trials of Selected Solid Tumours in Europe: Findings from EuroACT
2025 · Mercè Cases, Attila Imre, et al. · SSRN Electronic Journal
Works count: 23
Citation count: 44
H-index: 3
I10-index: 1
Year
Topic
Type